Literature DB >> 12845954

Factors affecting surgical outcome for gallbladder carcinoma.

Hirokazu Noshiro1, Kazuo Chijiiwa, Koji Yamaguchi, Syuji Shimizu, Atsushi Sugitani, Masao Tanaka.   

Abstract

BACKGROUND/AIMS: The outcome of advanced gallbladder carcinoma is dismal despite aggressive surgery. The aim of this study was to evaluate the surgical outcome and prognostic factors for patients with gallbladder carcinoma and to identify patients who may benefit from radical surgery.
METHODOLOGY: Fifty-six patients who underwent surgical resection of gallbladder carcinoma were retrospectively reviewed. Their tumor markers, operative management, pathological factors and survival were analyzed.
RESULTS: The serum carcinoembryonic antigen level was elevated in 9 of 51 patients (18%) with data available as was the serum carbohydrate antigen 19-9 level in 14 of 47 patients (30%). Univariate analysis showed that jaundice, serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels, the number, size, macroscopic type, and histological grade of the tumor, the depth of tumor invasion (pT), pathological stage, lymph node metastasis (pN), lymphatic invasion, vascular invasion, perineural infiltration, curability of lymph node dissection and surgical margins have prognostic significance for survival. Multivariate analysis revealed jaundice, high histological grade, pT3 or pT4, and surgical margins were independent prognostic factors for survival.
CONCLUSIONS: Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels are potential predictors and informative for survival. There are still difficulties to treat gallbladder carcinoma infiltrating beyond subserosa or revealing jaundice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12845954

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Metastasis of primary gallbladder carcinoma in lymph node and liver.

Authors:  Han-Ting Lin; Gui-Jie Liu; Dan Wu; Jian-Ying Lou
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

2.  Genomic determination of CR1 CD35 density polymorphism on erythrocytes of patients with gallbladder carcinoma.

Authors:  Xing-Yuan Jiao; Ming-De Lü; Jie-Fu Huang; Li-Jian Liang; Jing-Sen Shi
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

3.  Gallbladder cancer revealed by an endobiliary tumor thrombus.

Authors:  David Fuks; Vijay Borgaonkar; Sushil Deshpande; Vaishali Deshpande; Charlotte Mouly; Viraj Borgaonkar; Francois Mauvais; Vaishali Jadhav; Jean-Marc Regimbeau
Journal:  Indian J Surg       Date:  2012-12-09       Impact factor: 0.656

4.  Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy.

Authors:  Jae Woo Lee; Yong-Tae Kim; Sang Hyub Lee; Jun Hyuk Son; Jin Woo Kang; Ji Kon Ryu; Dong Kee Jang; Woo Hyun Paik; Ban Seok Lee
Journal:  Gut Liver       Date:  2018-01-15       Impact factor: 4.519

5.  Surgical outcome and prognostic factors in patients with gallbladder carcinoma.

Authors:  Eun Kyung Hong; Kun Kuk Kim; Jung Nam Lee; Woon Kee Lee; Min Chung; Yeon Suk Kim; Yeon Ho Park
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2014-11-30

6.  Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.

Authors:  A Nickkholgh; O Ghamarnejad; E Khajeh; P Tinoush; T Bruckner; Y Kulu; M Mieth; B Goeppert; S Roessler; K H Weiss; K Hoffmann; M W Büchler; A Mehrabi
Journal:  BJS Open       Date:  2019-09-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.